These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19445749)

  • 21. Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
    Zenner D; Beer N; Harris RJ; Lipman MC; Stagg HR; van der Werf MJ
    Ann Intern Med; 2017 Aug; 167(4):248-255. PubMed ID: 28761946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of latent tuberculosis infection in HIV: shorter or longer?
    Person AK; Sterling TR
    Curr HIV/AIDS Rep; 2012 Sep; 9(3):259-66. PubMed ID: 22581360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leprosy.
    Smith WC; Saunderson P
    BMJ Clin Evid; 2010 Jun; 2010():. PubMed ID: 21418690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV infection.
    Talbot M
    BMJ Clin Evid; 2008 Jul; 2008():. PubMed ID: 19445740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
    Cevik M; Thompson LC; Upton C; Rolla VC; Malahleha M; Mmbaga B; Ngubane N; Abu Bakar Z; Rassool M; Variava E; Dawson R; Staples S; Lalloo U; Louw C; Conradie F; Eristavi M; Samoilova A; Skornyakov SN; Ntinginya NE; Haraka F; Praygod G; Mayanja-Kizza H; Caoili J; Balanag V; Dalcolmo MP; McHugh T; Hunt R; Solanki P; Bateson A; Crook AM; Fabiane S; Timm J; Sun E; Spigelman M; Sloan DJ; Gillespie SH;
    Lancet Infect Dis; 2024 Sep; 24(9):1003-1014. PubMed ID: 38768617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of latent tuberculosis infection in HIV infected persons.
    Akolo C; Adetifa I; Shepperd S; Volmink J
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000171. PubMed ID: 20091503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolones for treating tuberculosis (presumed drug-sensitive).
    Ziganshina LE; Titarenko AF; Davies GR
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004795. PubMed ID: 23744519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
    Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE
    Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.
    Chirehwa MT; McIlleron H; Rustomjee R; Mthiyane T; Onyebujoh P; Smith P; Denti P
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous leg ulcers.
    Nelson EA
    BMJ Clin Evid; 2011 Dec; 2011():. PubMed ID: 22189344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonorrhoea.
    Moran JS
    BMJ Clin Evid; 2007 Mar; 2007():. PubMed ID: 19454057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV: mother-to-child transmission.
    Volmink J; Marais B
    BMJ Clin Evid; 2008 Feb; 2008():. PubMed ID: 19450331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    Rockwood N; Sirgel F; Streicher E; Warren R; Meintjes G; Wilkinson RJ
    J Infect Dis; 2017 Sep; 216(6):632-640. PubMed ID: 28934422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up.
    Harries AD; Kumar AMV; Satyanarayana S; Takarinda KC; Timire C; Dlodlo RA
    Expert Rev Respir Med; 2020 Feb; 14(2):195-208. PubMed ID: 31760848
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis C (chronic).
    Mohsen A; Norris S
    BMJ Clin Evid; 2010 Feb; 2010():. PubMed ID: 21718581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altitude sickness.
    Murdoch D
    BMJ Clin Evid; 2007 Jun; 2007():. PubMed ID: 19454083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.
    Whalen CC; Johnson JL; Okwera A; Hom DL; Huebner R; Mugyenyi P; Mugerwa RD; Ellner JJ
    N Engl J Med; 1997 Sep; 337(12):801-8. PubMed ID: 9295239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candidiasis (oropharyngeal).
    Pankhurst CL
    BMJ Clin Evid; 2009 Mar; 2009():. PubMed ID: 19445752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B (prevention).
    Norris S; Mohsen A
    BMJ Clin Evid; 2007 May; 2007():. PubMed ID: 19454073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.